Trial Profile
A Randomized Trial of Dihydroartemisinin-piperaquine (Malacur) versus Artemether-lumefantrine (Coartem) for Treatment of uncomplicated Plasmodium falciparum Malaria in Mali
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Dihydroartemisinin/piperaquine (Primary)
- Indications Falciparum malaria
- Focus Therapeutic Use
- Sponsors SALVAT
- 26 Jun 2018 New trial record